We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Health insurer Anthem is suing Express Scripts in federal court for nearly $15 billion, claiming that the PBM has overcharged and is refusing to renegotiate future drug prices. Read More
The FDA put a damper on Eagle Pharmaceuticals’ plans to market its blood thinner Kangio via a complete response letter not recommending approval. Read More
An ex-Turing executive took his former employer to task on Thursday, telling lawmakers the drugmaker’s decision to raise the price of Daraprim by 5,000 percent was “unjustified.” Read More
A jury sided with Amgen Wednesday in a suit accusing Regeneron and Sanofi of violating two of its patents when they developed a cholesterol-fighting biologic. Read More
Prescription drug prices rose 5.2 percent for customers of PBM Express Scripts in 2015, approximately half of the increase seen in 2014, the company stated Tuesday in its annual Drug Trend report. Read More
The FTC is arguing that a district court erred in failing to apply the Supreme Court ruling in FTC v. Actavis in a pay-for-delay case involving GlaxoSmithKline’s Wellbutrin XL antidepressant. Read More
Greater transparency of pharmaceutical pricing is the key to reducing the nation’s prescription drug tab, according to multiple comments sent to the Senate Finance Committee. Read More